144
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Measured levels of positive transglutaminase 2 antibodies are not associated with presentation or incidental endoscopic findings at celiac disease diagnosis

, , , , , & show all
Pages 419-424 | Received 18 Oct 2023, Accepted 19 Dec 2023, Published online: 02 Jan 2024

References

  • Myléus A, Ivarsson A, Webb C, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr. 2009;49(2):170–176. doi: 10.1097/MPG.0b013e31818c52cc.
  • Popp A, Kivelä L, Fuchs V, et al. Diagnosing celiac disease: towards wide-scale screening and serology-based criteria? Gastroenterol Res Pract. 2019;2019:2916010–2916024. doi: 10.1155/2019/2916024.
  • Singh P, Arora A, Strand TA, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(6):823–836.e2. doi: 10.1016/j.cgh.2017.06.037.
  • Elli L, Branchi F, Sidhu R, et al. Small bowel villous atrophy: celiac disease and beyond. Expert Rev Gastroenterol Hepatol. 2017;11(2):125–138. doi: 10.1080/17474124.2017.1274231.
  • Ravelli A, Villanacci V, Monfredini C, et al. How patchy is patchy villous atrophy? Distribution pattern of histological lesions in the duodenum of children with celiac disease. Am J Gastroenterol. 2010;105(9):2103–2110. doi: 10.1038/ajg.2010.153.
  • Taavela J, Koskinen O, Huhtala H, et al. Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease. Sestak K, editor. PLoS One. 2013;18(10):e76163. doi: 10.1371/journal.pone.0076163.
  • Fuchs V, Kurppa K, Huhtala H, et al. Serology-based criteria for adult coeliac disease have excellent accuracy across the range of pre-test probabilities. Aliment Pharmacol Ther. 2019;49(3):277–284. doi: 10.1111/apt.15109.
  • Werkstetter KJ, Korponay-Szabó IR, Popp A, et al. Accuracy in diagnosis of celiac disease without biopsies in clinical practice. Gastroenterology. 2017;153(4):924–935. doi: 10.1053/j.gastro.2017.06.002.
  • Husby S, Koletzko S, Korponay-Szabó IR, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136–160. doi: 10.1097/MPG.0b013e31821a23d0.
  • Husby S, Koletzko S, Korponay-Szabó I, et al. European society paediatric gastroenterology, hepatology and nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr. 2020;70(1):141–156. doi: 10.1097/MPG.0000000000002497.
  • Penny HA, Raju SA, Lau MS, et al. Accuracy of a no-biopsy approach for the diagnosis of coeliac disease across different adult cohorts. Gut. 2021;70(5):876–883. doi: 10.1136/gutjnl-2020-320913.
  • Ciacci C, Bai JC, Holmes G, et al. Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study. Lancet Gastroenterol Hepatol. 2023;8(11):1005–1014. 1253(23)00205-4.
  • Hoyle A, Gillett P, Gillett HR, et al. No-biopsy strategy for coeliac disease is applicable in adult patients: a ‘real-world’ scottish experience. Frontline Gastroenterol. 2023; 14(2):97–102. doi: 10.1136/flgastro-2022-102254.
  • Efthymakis K, Serio M, Milano A, et al. Application of the biopsy-sparing ESPGHAN guidelines for celiac disease diagnosis in adults: a real-life study. Dig Dis Sci. 2017;62(9):2433–2439. doi: 10.1007/s10620-017-4672-1.
  • Kurien M, Ludvigsson JF, Sanders DS, authors of the BSG guidelines. A no biopsy strategy for adult patients with suspected coeliac disease: making the world gluten-free. Gut. 2015; 64(6):1003–1004. doi: 10.1136/gutjnl-2014-308568.
  • Marks LJ, Kurien M, Sanders DS. The serological diagnosis of adult coeliac disease – a cautious step forward? Gastroenterol Hepatol Bed Bench. 2018;11(3):175–177.
  • Maimaris S, Schiepatti A, Gabrielli GM, et al. Low prevalence of upper endoscopic gastrointestinal findings despite high frequency of alarm symptoms at the time of diagnosis in adult coeliac disease. Eur J Gastroenterol Hepatol. 2020;32(11):1447–1451. doi: 10.1097/MEG.0000000000001829.
  • Stefanolo JP, Zingone F, Gizzi C, et al. Upper gastrointestinal endoscopic findings in celiac disease at diagnosis: a multicenter international retrospective study. World J Gastroenterol. 2022; 128(43):6157–6167. doi: 10.3748/wjg.v28.i43.6157.
  • Taavela J, Kurppa K, Collin P, et al. Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease. Clin Gastroenterol Hepatol. 2013;11(2):166–171.e1. doi: 10.1016/j.cgh.2012.09.030.
  • Fimlab.fi [Internet]. cited 2023 May 4]. Available from: https://fimlab.fi/tutkimus/5935.
  • Hällström O. Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis. Gut. 1989;30(9):1225–1232. doi: 10.1136/gut.30.9.1225.
  • Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut. 1994;35(6):776–778. doi: 10.1136/gut.35.6.776.
  • Mäki M. The humoral immune system in coeliac disease. Baillieres Clin Gastroenterol. 1995; 9(2):231–249. doi: 10.1016/0950-3528(95)90030-6.
  • Korponay-Szabó IR, Dahlbom I, Laurila K, et al. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Gut. 2003; 52(11):1567–1571.
  • Laugesen K, Ludvigsson JF, Schmidt M, et al. Nordic health Registry-Based research: a review of health care systems and key registries. Clin Epidemiol. 2021; 13:533–554. doi: 10.2147/CLEP.S314959.
  • Brar P, Kwon GY, Egbuna II, et al. Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease. Dig Liver Dis. 2007;39(1):26–29. doi: 10.1016/j.dld.2006.07.014.
  • Thomas HJ, Ahmad T, Rajaguru C, et al. Contribution of histological, serological, and genetic factors to the clinical heterogeneity of adult-onset coeliac disease. Scand J Gastroenterol. 2009; 44(9):1076–1083. doi: 10.1080/00365520903100473.
  • Mooney PD, Kurien M, Evans KE, et al. Clinical and immunologic features of ultra-short celiac disease. Gastroenterology. 2016; 150(5):1125–1134. doi: 10.1053/j.gastro.2016.01.029.
  • Aziz I, Peerally MF, Barnes JH, et al. The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK Centre experience evaluating 200 adult cases over a 15-year period (2000–2015). Gut. 2017;66(9):1563–1572. doi: 10.1136/gutjnl-2016-312271.
  • Salmi TT, Collin P, Korponay-Szabo IR, et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut. 2006;55(12):1746–1753. doi: 10.1136/gut.2005.071514.
  • Schiepatti A, Rej A, Maimaris S, et al. Clinical classification and long-term outcomes of seronegative coeliac disease: a 20-year multicentre follow-up study. Aliment Pharmacol Ther. 2021; 54(10):1278–1289. doi: 10.1111/apt.16599.
  • Ilus T, Kaukinen K, Virta LJ, et al. Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease. Aliment Pharmacol Ther. 2014;39(4):418–425. doi: 10.1111/apt.12606.
  • Deane C, O’Connor E, Donovan H, et al. O’ The strategic use of biopsy in the diagnosis of coeliac disease in adults. Digestive and Liver Disease [Internet]. 2023 Aug 16 [cited 2023 Aug 23];0(0). Available from: https://www.dldjournalonline.com/article/S1590-8658(23)00773-9/fulltext.
  • Salo M, Collin P, Kyrönpalo S, et al. Age, symptoms and upper gastrointestinal malignancy in primary care endoscopy. Scand J Gastroenterol. 2008;43(1):122–127. doi: 10.1080/00365520701659175.
  • Aro P, Storskrubb T, Ronkainen J, et al. Peptic ulcer disease in a general adult population. Am J Epidemiol. 2006; 163(11):1025–1034. doi: 10.1093/aje/kwj129.
  • Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a kalixanda study report. Scand J Gastroenterol. 2005;40(3):275–285. doi: 10.1080/00365520510011579.
  • Sipponen P, Sarna S, Vohlonen I. When will Helicobacter pylori gastritis disappear in history in Finland? Scand J Gastroenterol. 2022;57(2):154–157. doi: 10.1080/00365521.2021.1998605.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.